3D Gait analysis with people with achondroplasia

Otto-von-Guericke-Universität Magdeburg, Institut III0 sites150 target enrollmentAugust 28, 2023

Overview

No summary available.

Registry

who.int

Start Date

August 28, 2023

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Otto-von-Guericke-Universität Magdeburg, Institut III

•Achondroplasia Group:
•\- A parent or legal guardian who signs the consent form and the subjects information for the subject.
•\- Clinical diagnosis of achondroplasia by the Faculty of Medicine/University Hospital A.ö.R. (FME/UKMD)
•University Children's Hospital (KPAE) (Dr. Palm)
•\- An age between 6 to 18 years
•\- The ability to walk barefoot independently without an assistive device
•\- Current medical treatment of e.g. vosoritides, orthopedic interventions) or human growth hormones or other medical products that have the intention of influencing body size or body disproportions will be documented at all time points
•Control group:
•\- A parent or legal guardian who will sign the informed consent form and subject information form for the subject
•\- The ability to follow the test protocol as judged by a member of the measurement team.

•Achondroplasia Group:
•\- Skeletal dysplasias other than achondroplasia or medical conditions resulting in decreased body size or abnormal bone growth
•\- Dependence on orthotics or assistive devices for locomotion
•\- Hemieepophysiodesis (\< 3 months)
•\- Lengthening of extremities/ osteotomy with full recovery are included with a minimum healing time of 12 months
•\- Past or present injury or disease to the growth plate(s), other than ACH, that affects the growth potential of the bones
•\- Decompression of the foramen magnum and a laminectomy with a complete recovery are allowed with a minimum healing time of 6 months.
•Control group:
•\- Past lower extremity injuries within the last six months that required medical treatment.
•\- Past orthopedic treatments